Search
CNS_Partnering_Interests-2018-12.pdf
Grass_Roots_Partnering_Initiatives.pdf
CardioMetabolic_Partnering_Interests_2018-12.pdf
CNS_Partnering-2019-01.pdf
Immunology_Partnering_Interests_2018-12.pdf
Oncology_Partnering_Interests-2018-12.pdf
RBB_Partnering_Interests-2018-12.pdf
Respiratory_Partnering_Interests_2018-12.pdf
Technologies_Partnering_Interests-2018-12.pdf
Partnering in Technologies HP SEPT 2024 CORP_0.pdf
Partnering in Technologies AH MAY 2024 CORP.pdf
Partnering in Oncology & Cancer Imm HP OCTOBER 2024 CORP.pdf
Partnering in RBB HP OCTOBER CORP.pdf
Partnering in Biotherapeutics HP OCTOBER 2024 CORP_1.pdf
Partnering in Technologies HP OCTOBER 2024 CORP.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
Partnering with Boehringer Ingelheim HP OCTOBER 2024 CORP.pdf
Partnering in Immunology & Resp HP OCTOBER 2024 CORP.pdf
Our Expectations
We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners.
Mexico rabies free dog vaccination campaigns
Mexico: a champion in the fight against rabies. The first country in the world to be declared free from dog-transmitted rabies.
PRRS vaccine celebrates 25 years in Europe
Boehringer Ingelheim celebrates 25 years to combat PRRS in Europe
Purchasing
Purchasing at Boehringer Ingelheim
Life forward
In everything we do we can shape and influence the future for the better: Learn more about “Life forward” and how our innovations improve lives.
Transforming Science Day Europe
Oct. 2, 2023: Join us in London, or virtually, to learn more about our patient-centric approach to innovation, advancing pipeline and partnering approach.